Getinge

Regulatory Filings • Jan 7, 2008

The competition authorities have approved Getinge's acquisition of Boston Scientific Corporations Cardiac and Vascular Surgery division

The acquisition of the business, published on the 5th November 2007, was conditional on the approval of competition authorities concerned.

Getinge today announces that competition authorities concerned have approved the acquisition. The condition for the acquisition has thus been fulfilled and the transaction with Boston Scientific has been finalized.

Getinge regards the acquisition of the Cardiac Surgery and Vascular Surgery divisions of Boston Scientific Corp as a strong base for further expansion in the global market for medical devices, equipment and instruments for the cardiac surgery. Getinge currently has a successful operation in the perfusion area of the cardiac surgery market, with strong market positions and sales channels in Europe and in a number of developing markets. By marketing Cardiac Surgery's and Vascular Surgery's products through Getinge's Business Area Medical Systems´ sales channels outside the US, it is expected that it will be possible to considerably improve the market share and growth in these markets. In a corresponding manner, the introduction of Cardiopulmonary's products into the newlyacquired Cardiac Surgery's strong sales organisation in the US will lead to more rapid growth for the Group's perfusion products.

The divisions will be consolidated into Getinge's accounts from January this year.

Getinge, 7th January 2008 Johan Malmquist, President and CEO

Getinge Internet address http://www.getingegroup.com

The information provided herein is such that Getinge AB is obligated to disclose pursuant to the Securities and Clearing Operations Act and/or the Financial Instruments Trading Act.

Getinge AB (publ) Ekebergsvägen 26, P O Box 69 S-310 44 Getinge, Sweden Phone: +46 35 15 55 00 Fax. +46 35 15 56 40 info@getinge.com www.getingegroup.com